Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5612577 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL5612283 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL5612723 | 0.80 | CYP1A2 (0.30) | — | |
| Hydrochloric Acid SCHEMBL29790381 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL967315 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL394875 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL2531883 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL392658 | 0.74 | CYP11B1 (0.33) | CYP11B1CYP11B2 | |
| Hydrochloric Acid SCHEMBL393886 | 0.74 | CYP19A1 (0.30) | CYP11B1CYP11B2 | |
| Hydrochloric Acid SCHEMBL968811 | 0.74 | CYP19A1 (0.30) | CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7211537-B2 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2007-05-01 | — | — | US | disclosed |
| US-20050197471-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2005-09-08 | — | — | US | disclosed |
| US-6921800-B2 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040224838-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | FUJITA MASAYUKI (JP) | 2004-11-11 | — | — | US | disclosed |
| US-6664208-B1 | For synthesis of highly stereoregular high molecular weight alphaolefin polymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197471-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | AHR, ALOX5AP, ALOX15B | CYP11B1 1367/4885CYP11B2 1259/4885HTR2A 3102/4885 |
| US-20040224838-A1 | Modified aluminum oxy compound, polymerization catalyst and process for producing olefin polymer and alkenyl aromatic hydrocarbon polymer | AHR, ALOX5AP, ALOX15B | CYP11B1 1367/4885CYP11B2 1259/4885HTR2A 3102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.